Lemaitre Vascular LMAT
NASDAQ LMAT
$81.86 -0.46 (-0.56%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lemaitre Vascular (LMAT) Invested Capital (2020 - 2021)

Lemaitre Vascular (LMAT) posted quarterly Invested Capital of $3.0 million for Q2 2021, up 50.0% year-over-year from $2.0 million in Q2 2020, and up 20.0% quarter-over-quarter from $2.5 million in Q4 2020.

Lemaitre Vascular (LMAT) Invested Capital (2020 - 2021) Analysis & Trends

Lemaitre Vascular (LMAT) has reported Invested Capital for 2 consecutive years, with $3.0 million the latest figure, recorded in Q2 2021.

  • In Q2 2021, Invested Capital rose 50.0% year-over-year to $3.0 million; the TTM figure through Mar 2022 stood at $3.0 million (down 55.56% YoY), while the FY2020 annual figure was $2.5 million, changed N/A from the prior year.
  • Invested Capital advanced to $3.0 million in Q2 2021 per LMAT's latest filing, from $2.5 million in the prior quarter.
  • Across five years, Invested Capital topped out at $3.0 million in Q2 2021 and bottomed at $2.0 million in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 3.30 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn 4.72 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 259.95 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 29.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 209.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn 598.90 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 844.00 Mn
10 Lemaitre Vascular 1.88 Bn 1.50 Bn 50.76 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2021 3.00 Mn
Dec 31, 2020 2.50 Mn
Sep 30, 2020 2.25 Mn
Jun 30, 2020 2.00 Mn